|

When we talk about Calox International, we're talking about
a company evolving throughout the years. In 1953, it started
operations as Laboratorios Biogen, C.A. Later, in 1966, it
entered into a partnership with McKesson - an acknowledged
US corporation with experience in the medical field since
1833. By mid 1971, after a shares amendment and strengthening
both the technological and marketing areas, it became Laboratorios
Calox, C.A. In 1966 Laboratorios Calox resolved to join the
globalization process by starting operations in Central America
and changing its name to Calox International C.A. in 1998
thus reaffirming its corporate purpose: trading and manufacturing
generic drugs for human and veterinary uses.
PREMISES
At its Caracas location, Calox International counts with a
state-of- the- art pharmaceutical facility of approximately
10,500 mts surface. This building houses both managerial and
administrative functions, as well as Research and Development,
Production and Raw Material Storage, Finished Products Stocks,
employees dining room and maintenance areas. The company is
located in Los Cortijos Industrial Area, within Caracas eastern
sector. These premises ensure an quite comfortable work environment,
including the best work hygiene and safety features showing
that workers, community and environment are duly taken into
account.
PRODUCTION
Calox
International currently has an installed capacity of approximately
53 million finished units per annum. Production under a sole
work shift reflects our potential to double products yield,
whenever necessary. Total units yield can be spread as follows:
|
Non-penicillin
- compounds Pharmaceutical Shape
|
M.M.
units
|
|
Syrup
(bottles)
|
5.24
|
|
Drops
(bottles)
|
4.59
|
|
Ampoule
|
13.02
|
|
Creams
(tube)
|
3.6
|
|
Solids
(capsules or caplets packing)
|
17.45
|
|
Total
Non-penicillin compounds
|
43.9
|
|
Penicillin
- compounds Pharmaceutical Shape
|
M.M.
units
|
|
SSolids
(capsules or caplets packing)
|
5.5
|
|
Powder
for suspensions (bottles)
|
1.7
|
|
Injectable
(bottles-ampoules)
|
2.0
|
|
Total
penicillin compounds
|
9.2
|
MANUFACTURING
SERVICES
DesSince year 2000, Calox International has
widened its business scope by entering into and wining several
bids to manufacture drugs for other domestic and transnational
pharmaceutical companies. This positive experience allows
us to offer our manufacturing and packing services for anyone
searching for a trustworthy and efficient supplier to ensure
its ongoing products supply into the markets under the highest
quality standards. Please contact us through our e-mail: nuevosnegocios@calox.com,
we will be pleased to answer your request.
PURPOSE OF A PHARMACEUTICAL
LAB
We all know that healthy
people are a main driver for any country's economic development,
as well as its productivity and growth potentials. In Calox
International we are aware of the primary role played by the
pharmaceutical industry among those variables affecting any
country's Life Quality, as they provide solutions to health
and wellness needs had by societies.
|